Security key
98943L107
Zentalis Pharmaceuticals, Inc. - Common Stock (ZNTL)
CUSIP: 98943L107
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 67,021,594
- Total 13F value
- $1,152,767,927
- Share change
- +2,678,545
- Put/Call ratio
- 192%
- SEC-reported price per share
- $17.20
- Number of holders
- 108
- Value change
- +$44,945,526
- Number of buys
- 53
- Number of sells
- 44
- Shares outstanding
- 71,363,731
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
108
Top holders
10
ZNTL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Zentalis Pharmaceuticals, Inc. SEC filings
Zentalis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98943L107
Recent filing periods:
Ownership snapshot
Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
Matrix Capital Management Company, LP leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Matrix Capital Management Company, LP's linked filing trail.
Comparable ownership
Top 5
Matrix Capital Management Company...
13%
FMR LLC
11%
Avidity Partners Management LP
7.2%
VANGUARD GROUP INC
5.8%
WELLINGTON MANAGEMENT GROUP LLP
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP |
13F
Company
|
13%
|
$185,287,456
9,199,973 shares
|
— | 31 Dec 2022 |
| FMR LLC |
13F
Company
|
11%
|
$159,290,805
7,909,176 shares
|
— | 31 Dec 2022 |
| Avidity Partners Management LP |
13F
Company
|
7.2%
|
$103,721,000
5,150,000 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
5.8%
|
$83,785,400
4,160,149 shares
|
— | 31 Dec 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
5.1%
|
$72,876,448
3,618,493 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.9%
|
$69,929,685
3,472,179 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
108
Shares
67,021,594
Rows available
108
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
108
Q1 2023 holders
108
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend